Cancer predisposition syndrome such as Li–Fraumeni syndrome (LFS) with TP53 mutation generally promotes the onset of various benign and malignant neoplasms, such as neuroblastoma (NB), osteosarcoma (OS), soft tissue sarcomas (STS), and brain tumors [37]. The gene discussed is TP53; the disease is cancer.